Blood test spots hidden cancer after surgery in HPV head & neck patients
NCT ID NCT06730412
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new blood test (liquid biopsy) to see if it could find any cancer left behind after surgery in 103 people with HPV-related head and neck cancer. The goal was to catch remaining disease early, which could help doctors decide if more treatment is needed. The test looks for tumor DNA in the blood, offering a less invasive way to monitor patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may tailor throat cancer treatment, sparing patients from harsh side effects
- Robotic surgery may spare throat cancer patients from chemo and radiation
- Vaccine trains immune system to fight HPV-Positive head and neck tumors
- New Vaccine-Drug combo aims to tame HPV throat cancer with less radiation
- Can less radiation be just as good for HPV throat cancer?
- New combo aims to tame HPV throat cancer with fewer side effects